Latest Content

Daisy Molina, EdD, MSN, RNC-LRN, discusses listening, honest reassurance, and lifelong communication skills for nurses facing hard conversations.

In 1,071 women diagnosed at 40 or younger, lower income was tied to delayed presentation and younger age to delayed diagnosis.

A Columbia nurse scientist shares her takeaways from the 2026 ASCO Quality Care Symposium, from geriatric assessment to care across the age span.

A patient, a caregiver, nurses, an NP, and an oncologist discuss rash prevention, dose holds, cost, and trial eligibility with oral daraxonrasib.

Daisy Molina, EdD, MSN, RNC-LRN, explains how nurses can include caregivers in breast cancer care while keeping the patient's voice central.

In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.

Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.

FDA grants accelerated approval to amivantamab and hyaluronidase-lpuj for recurrent or metastatic head and neck squamous cell carcinoma.

Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.

Daisy Molina, EdD, MSN, RNC-LRN, details how nursing students learn to deliver hard news with empathy, plain language, and team support.

Among 90 patients with ES-SCLC, all CRS in the outpatient cohort was grade 1, and no patient in any care model was readmitted.

At the 2026 National Summit on Hematologic Cancers, Kate Kennedy, MSN, APRN, flagged decisions where guidelines give nurses and APPs little direction.

Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.